Promising Pancreatic Cancer Data

This week we highlight some promising clinical research in the pancreatic cancer space. Daraxonrasib has shown OS benefit vs. chemo in the 2nd-line setting of metastatic pancreatic cancer compared to investigator's choice chemotherapy. Hopefully, we will get the abstract soon and publication shortly thereafter. A personalized mRNA vaccine for early-stage pancreatic cancer has some encouraging results (for those patients who mounted a sizable immune response to the vaccine). Check out the Oncology Insights Newsletter:

You can listen to Promising Pancreatic Cancer Data online on Radio and Podcast. Open the player on this page to stream the available audio.

Promising Pancreatic Cancer Data is an episode from OncoPharm by OncoPharmPod.

This episode is 00:13:56 long.

This episode was published on Apr 23, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.